The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation

American Journal of Industrial Medicine

Volumn 57, Issue 4, 2014, Pages 383-397

  Soffritti, Morando ^a   Padovani, Michela ^a   Tibaldi, Eva ^a   Falcioni, Laura ^a   Manservisi, Fabiana ^a   Belpoggi, Fiorella ^a  

^a Ramazzini Institute   (Italy)

Author keywords

Animal models; Aspartame; Carcinogenicity; Long term experimental bioassays; Public health

Indexed keywords

ASPARTAME; CARCINOGEN; NONNUTRITIVE SWEETENER;

ANIMAL; ANIMAL MODELS; ARTICLE; CARCINOGEN TESTING; CARCINOGENICITY; CHEMICALLY INDUCED DISORDER; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; LONG-TERM EXPERIMENTAL BIOASSAYS; NEOPLASM; PRODUCT SAFETY; PUBLIC HEALTH; STANDARD; UNITED STATES;

ANIMAL MODELS; ASPARTAME; CARCINOGENICITY; LONG-TERM EXPERIMENTAL BIOASSAYS; PUBLIC HEALTH;

ANIMALS; ASPARTAME; CARCINOGENICITY TESTS; CARCINOGENS; CONSUMER PRODUCT SAFETY; EUROPE; HUMANS; NEOPLASMS; NON-NUTRITIVE SWEETENERS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84896705152     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.22296     Document Type: Article

References (59)

1. Belpoggi F, Soffritti M, Padovani M, Degli Esposti D, Lauriola M, Minardi F. 2006. Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed. Ann NY Acad Sci 1076:559-577.
2. Bucher JR. 2002. The National Toxicology Program rodent bioassay: Designs, interpretations, and scientific contributions. Ann NY Acad Sci 982:198-207.
3. Caldwell JC, Jinot J, DeVoney D, Gift JS. 2008. Evaluation of evidence for infection as a mode of action for induction of rat lymphoma. Environ Mol Mutagen 49:155-164.
4. Cogliano VJ. 2006. Use of carcinogenicity bioassays in the IARC monographs. Ann NY Acad Sci 1076:592-600.
5. De la Peña C. 2010. Empty pleasures the story of artificial sweeteners from saccharin to splenda. Chapel Hill, NC: University of North Carolina Press.
6. 1992. Decreto Legislativo 116 1992. Attuazione della direttiva. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian]. Gazzetta Ufficiale Supplemento ordinario. pp. 5-25.
7. EFSA. 2006. Scientific opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame. EFSA J Eur Food Safety Authority 356:1-44.
8. EFSA. 2009. Updated opinion on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame, taking into consideration study data submitted by the Ramazzini Foundation in February 2009. EFSA J Eur Food Safety Authority 945:1-18.
9. EFSA. 2011. Call for scientific data on Aspartame (E 951) http://www.efsa.europa.eu/en/dataclosed/call/110601.htm.
10. EFSA. 2011a. Statement on the scientific evaluation of the studies related to the safety of artificial sweeteners. EFSA J Eur Food Safety Authority 9:2089-2105.
11. EFSA. 2011b. Statement on two recent scientific articles on the safety of artificial sweeteners. EFSA J Eur Food Safety Authority 9:1996-2001.
12. EFSA. 2013. DRAFT Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive. http://www.efsa.europa.eu/en/consultationsclosed/call/130108.pdf.
13. EPA. 1984. Good Laboratory Practices Standards in Environmental Protection Agency-Fungicides, Insecticides and Rodenticides Act. 48 Federal Register 53946. Environmental Protection Agency.
14. European Parliament and Council. 1994. Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs OJ L 237 10.9.199. pp. 3-12.
15. FDA. 1981. Aspartame: Commissioner's final decision. Fed Reg (Food and Drug Administration) 46:38285-38308.
16. FDA. 1983. Food additives permitted for direct addition to food for human consumption: Aspartame. Fed Reg (Food and Drug Administration) 48:31376-31382.
17. FDA. 1996. Food additives permitted for direct addition to food for human consumption: Aspartame. Fed Reg (Food and Drug Administration) 61:33654-33656.
18. FDA. 2000. Toxicological principles for the safety assessment of food ingredients: FDA Redbook 2000: Section IV.B.1. General guidelines for designing and conducting toxicity studies. November 2003. Washington, DC: Food and Drug Administration. p. 18
19. FDA. 2007. Center for Food Safety and Applied Nutrition. FDA Statement on European Aspartame Study. April 20, 2007: Food and Drug Administration. Food Navigator. http://www.foodnavigator.com/.
20. Gift JS, Caldwell JC, Jinot J, Evans MV, Cote I, Vandenberg JJ. 2013. Scientific Considerations for Evaluating Cancer Bioassays Conducted by the Ramazzini Institute. Environ Health Perspect 12(11-12):1253-1263.
21. Goodman JE, Beyer LA, Beck BD. 2009. Comment on "Evaluation of evidence for infection as the mode of action for induction of rat lymphoma" by Caldwell et al. [2008]. Environ Mol Mutagen 50:4-5 ; author reply 6-9.
22. Hayes AW, Dayan AD, Hall WC, Kodell RL, Williams GM, Waddell WD, Slesinski RS, Kruger CL. 2011. A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients. Regul Toxicol Pharmacol 60:S1-S34.
23. Huff J. 2002. Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: In tribute to Cesare Maltoni and David Rall. Ann NY Acad Sci 982:208-230.
24. Huff J. 2010. Predicting chemicals causing cancer in animals as human carcinogens. Occup Environ Med 67:720.
25. Huff J, LaDou J. 2007. Aspartame bioassay findings portend human cancer hazards. Int J Occup Environ Health 13:446-448.
26. Ishii H. 1981. Incidence of brain tumors in rats fed aspartame. Toxicol Lett 7:433-437.
27. Ishii H, Koshimizu T, Usami S, Fujimoto T. 1981. Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks. Toxicology 21:91-94.
28. Iwata H. 2006. Histopathological examination in a carcinogenicity study of SC-18862 in Wistar rats. [Non-GLP study]. Experiment No. 9748 (258-049). Unpublished report. Ajinomoto Co., Inc. p. 1-877. Citation retrived in Efsa 2013 Draft Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive.
29. Landrigan PJ. 1999. Risk assessment for children and other sensitive populations. Ann NY Acad Sci 895:1-9.
30. Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon R, Campbell D, Hollenbeck AR, Schatzkin A. 2006. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev 15:1654-1659.
31. Littlefield NA, Farmer JH, Gaylor DW, Sheldon WG. 1980. Effects of dose and time in a long-term, low-dose carcinogenic study. J Environ Pathol Toxicol 3:17-34.
32. Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM. 2007. Aspartame: A safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol 37:629-727.
33. Maltoni C, Soffritti M, Belpoggi F. 1999. The scientific and methodological bases of experimental studies for detecting and quantifying carcinogenic risks. Ann NY Acad Sci 895:10-26.
34. Marinovich M, Galli CL, Bosetti C, Gallus S, La Vecchia C. 2013. Aspartame, low-calorie sweeteners and disease: Regulatory safety and epidemiological issues. Food Chem Toxicol 60:109-115.
35. Maronpot RR, Flake G, Huff J. 2004. Relevance of animal carcinogenesis findings to human cancer predictions and prevention. Toxicol Pathol 32(Suppl. 1):40-48.
36. Mehlman MA. 2009. The power of the industrial lobby: Controversy, doupt, contradiction, lies and deceit and attacks on the Ramazzini Institute. Eur J Oncol 14:223-229.
37. Melnick RL, Thayer KA, Bucher JR. 2008. Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies. Environ Health Perspect 116:130-135.
38. Misra H, Soni M, Silawat N, Mehta D, Mehta BK, Jain DC. 2011. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats. J Pharm Bioallied Sci 3:242-248.
39. Mitsumori K, Boorman GA. 1990. Spinal cord and peripheral nerves. Benign and malignant schwannoma (neurilemoma). In: Boorman, GAES, Elwell MR, Montgomery CA, MacKenzie WF Jr, editors. Pathology of the Fischer rat. San Diego, CA: Academic Press. pp. 179-191.
40. National Toxicology Program. 2005. NTP report on the toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (feed studies). National Toxicology Program genetically modified model report: 1-222.
41. NTP and EPA. 2011. Summary Report of the National Toxicology Program and Environmental Protection Agency-Sponsored Review of pathology Materials from Selected Ramazzini Institute Rodent cancer Bioassays. http://ntp.niehs.nih.gov/NTP/About_NTP/Partnerships/International/SummaryPWG_Report_RI_Bioassays.pdf.
42. OECD. 2009. Guideline for the testing of chemicals. Test guideline 451: Carcinogenicity studies: Organization for Economic Cooperation and Development. p. 15.
43. Pathology Working Group. 2004. Chairperson's Report: lifetime study in rats conducted by the Ramazzini Foundation. Prepared by JR Hailey (Pathology Working Group Chair) NIEHS and submitted to F.elpoggi November 30, 2004.
44. Rao GN, Haseman JK, Edmondson J. 1989. Influence of viral infections on body weight, survival, and tumor prevalence in Fischer 344/NCr rats on two-year studies. Lab Anim Sci 39:389-393.
45. Rao GN, Piegorsch WW, Crawford DD, Edmondson J, Haseman JK. 1989. Influence of viral infections on body weight, survival, and tumor prevalence of B6C3F1 (C57BL/6N x C3H/HeN) mice in carcinogenicity studies. Fundam Appl Toxicol 13:156-164.
46. Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WW, Feskanich D. 2012. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr 96:1419-1428.
47. Schoeb TR, McConnell EE, Juliana MM, Davis JK, Davidson MK, Lindsey JR. 2009. Mycoplasma pulmonis and lymphoma in bioassays in rats. Vet Pathol 46:952-959.
48. Simon FR, Fortune J, Iwahashi M, Sutherland E. 2002. Sexual dimorphic expression of ADH in rat liver: Importance of the hypothalamic-pituitary-liver axis. Am J Physiol Gastrointest Liver Physiol 283:G646-G655.
49. Soffritti M, Belpoggi F, Degli Esposti D, Falcioni L, Bua L. 2008. Consequences of exposure to carcinogens beginning during developmental life. Basic Clin Pharmacol Toxicol 102:118-124.
50. Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L. 2005. Aspartame induces lymphomas and leukaemias in rats. Eur J Oncol 10:107-116.
51. Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A. 2006. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ Health Perspect 114:379-385.
52. Soffritti M, Belpoggi F, Manservigi M, Tibaldi E, Lauriola M, Falcioni L, Bua L. 2010. Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. Am J Ind Med 53:1197-1206.
53. Soffritti M, Belpoggi F, Minardi F, Bua L, Maltoni C. 1999. Mega-experiments to identify and assess diffuse carcinogenic risks. Ann NY Acad Sci 895:34-55.
54. Soffritti M, Belpoggi F, Minardi F, Maltoni C. 2002. Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results. Ann NY Acad Sci 982:26-45.
55. Soffritti M, Belpoggi F, Tibaldi E, Degli Esposti D, Lauriola M. 2007. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect 115:1293-1297.
56. Sontag JM, Page NP, Saffiotti U, Sontag JM, Page NP, Saffiotti U. 1976. Guidelines for carcinogen bioassay in small rodents. Washington, DC: National Institutes of Health.
57. Swenberg JA, Hoel DG, Magee PN. 1991. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res 51:6409-6414.
58. Talbot JM, Fisher KD. 1978. The need for special foods and sugar substitutes by individuals with diabetes mellitus. Diabetes Care 1:231-240.
59. Tomatis L. 1979. The predictive value of rodent carcinogenicity tests in the evaluation of human risks. Ann Rev Pharmacol Toxicol 19:511-530.